Arecor Therapeutics Shares Jump as Vaccine Patent Is Upheld by European Patent Office
11 October 2021 - 8:34PM
Dow Jones News
By Jaime Llinares Taboada
Shares in Arecor Therapeutics PLC climbed Monday morning after
its polysaccharide vaccine patent was upheld by the European Patent
Office.
The EPO was considering an appeal filed by GlaxoSmithKline PLC,
but this was dismissed.
Arecor said its patent protects novel compositions of a specific
type of vaccines, called polysaccharide vaccines, which are used to
prevent degradation.
Polysaccharide vaccines are used to protect against diseases
such as meningitis and pneumonia.
Shares at 0855 GMT were up 9.2% at 415 pence.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com;
@JaimeLlinaresT
(END) Dow Jones Newswires
October 11, 2021 05:19 ET (09:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Arecor Therapeutics (LSE:AREC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arecor Therapeutics (LSE:AREC)
Historical Stock Chart
From Apr 2023 to Apr 2024
